Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorUniversity College, London
About this trial
A single centre IDEAL Stage 1 feasibility study using novel electrophysiological recording techniques in adult participants undergoing neurosurgery. This is a first in human study, building upon previous preclinical mice experiments.
Participants will undergo their planned neurosurgical procedure as normal. In addition to their standard treatment neurophysiological monitoring including an electrocorticography electrode placed on the brain deep to the retractor will be used to monitor for signs of brain retraction injury.
Eligibility criteria
Qualifiers
Patients aged 16 or older undergoing intracranial surgery where it is anticipated fixed brain retraction will be used.
Disqualifiers
Patients without capacity to give consent at time of recruitment
Trial design
Treatments tested in this trial
- ECOG Array
Treatment groups
6 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov